MedPath

Clinical Role of Panchawalkala Ghrita Yonipichu in Pittaja Yonivyapad

Not yet recruiting
Conditions
Other specified noninflammatory disorders of vagina. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,
Registration Number
CTRI/2025/05/086690
Lead Sponsor
DR AMRAPALI BHIMRAO BANSOD
Brief Summary

**Purpose Of The Study :-**

Investigating Pittaja Yonivyapada And Its Impact On Women’s Health And Treating Pittaja Yonivyapada Effectively Is Essential To Prevent The Long-Term Health Consequences Associated With This Disorder.

**Aim :-**

The aim of this study is to investigate the etiology, symptoms, and management of pittaja yonivyapada, a condition primarily caused by the consumption of excessive katu, amla, lavana, and ksharadi pittavardhak aahara.

**Objectives :-** The primary objective of this study is to investigate pittaja yonivyapada, its causes, symptoms, and implications for women’s fertility and overall health. Specifically, the study will explore the relationship between pitta imbalance and the development of various symptoms like burning sensations, inflammation, pain, and excessive vaginal discharge. Furthermore, the study will examine the importance of proper treatment to avoid potential complications such as infertility, abnormal uterine bleeding, and other reproductive disorders

**Hopothesis:-**

**1.****Null Hopothesis :**

Panchawalkala Siddha Ghrita Yonipichu Is Not Effective In The Management Of Pittaja Yonivyapada.

**2.  Alternate Hypothesis :**

Panchawalkala Siddha Ghrita Yonipichu Is Effective In The Management Of Pittaja Yonivyapada.

**Procedure: -** ( Procedure For The Management Of Yonivyapada)                     Approval from the institutional ethical committee (iec) will be taken before commencement of the study.

**1. Diagnosis (Nidan) :**                 A thorough understanding of the patient’s symptoms and underlying causes is crucial. In ayurvedic practice, diagnosis is based on a detailed Evaluation Of The Patient’s History (Prakriti), Symptoms (Lakshana), And Dosha Involvement.

**2****.Diet And Lifestyle Modification (Aahar-Vihar) :**

**1. Foods To Avoid :-** Katu (Spicy), Amla (Sour), Lavana (Salty),  And Kshara (Alkaline) Foods As They Aggravate Pitta Dosha.Fried, Acidic, And Heavily Processed Foods.Excessive Consumption Of Alcohol And Stimulants Like Caffeine **2. Foods To Include :-** Pitta-Pacifying Foods: Foods That Are Sweet, Bitter, And Astringent In Taste.Fresh Fruits Like Coconut, Melons, Cucumbers, And Pears. Herbal Treatments And Remedies :Shatavari,Ashoka,Guduchi,Brahmi Etc.

**3.** **Panchakarma (Detoxification) :**-Virechana(Purgation),Basti (Enema),Abhyanga (Oil Massage),Shirodhara

**4. Monitoring And Follow-Up**

Rescue Medications Duly Prescribed By Physician Will Be Continued  Along With The Physiotherapeutic Approach In Both The Groups During The Study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
70
Inclusion Criteria

Diagnosed cases of pittaja yonivyapad pelvic inflammatory disease Married women Non pregnant women.

Exclusion Criteria
  • Unmarried women Pregnant women Patients with Uncontrolled Diabetes Hypertension Asthma Patients with malignancies sexually transmitted disease intrauterine contraceptive device.
  • HIV HBsAG positive Patients with exclusively vulvitis and bartholinitis Patients not willing to give informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief form yonigatdaha and yonigat vedana7 Days
Secondary Outcome Measures
NameTimeMethod
Relief From Signs And Symptoms14 Days

Trial Locations

Locations (1)

LRP Ayurvedic Medical College and Hospital and PG Institute and Research Centre Uran Islampur

🇮🇳

Sangli, MAHARASHTRA, India

LRP Ayurvedic Medical College and Hospital and PG Institute and Research Centre Uran Islampur
🇮🇳Sangli, MAHARASHTRA, India
DR AMRAPALI BHIMRAO BANSOD
Principal investigator
8080563554
amrapalibansod96@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.